Sensorion SA (EPA:ALSEN)
0.3500
-0.0250 (-6.67%)
Jan 30, 2026, 5:36 PM CET
Sensorion Market Cap
Sensorion has a market cap or net worth of €105.12 million as of January 30, 2026. Its market cap has decreased by -47.92% in one year.
Market Cap
105.12M
Enterprise Value
49.61M
Revenue
5.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.35
Market Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 105.12M, an increase of 413.88%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 105.12M | 3.82% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 278.85M |
| Transgene | 248.09M |
| Cellectis | 235.06M |
| Innate Pharma | 145.05M |
| ABIONYX Pharma | 134.06M |
| Adocia | 125.40M |
| MaaT Pharma | 117.57M |
| OSE Immunotherapeutics | 106.54M |